ViroGuard
Generic Name
Enviral
Manufacturer
PharmaGlobal Inc.
Country
USA
Loading images...
Description
Overview of the medicine
Enviral is a broad-spectrum experimental antiviral agent indicated for the treatment of various viral infections. It aims to inhibit viral replication by targeting key enzymes.
Uses & Indications
Dosage
Adults
200 mg orally twice daily for 5-7 days.
Elderly
No specific dose adjustment required, monitor renal function.
Renal_impairment
Dose reduction recommended for CrCl < 30 mL/min.
How to Take
Take orally with or without food. Complete the full course of treatment as prescribed, even if symptoms improve.
Mechanism of Action
Enviral acts as an RNA polymerase inhibitor, preventing the synthesis of viral genetic material and subsequently halting viral replication within host cells.
Pharmacokinetics
Onset
Antiviral effects typically observed within 24-48 hours of initiation.
Excretion
Mainly excreted renally as unchanged drug and metabolites.
Half life
Approximately 4-6 hours, requiring twice-daily dosing.
Absorption
Rapidly absorbed orally, with peak plasma concentrations achieved within 1-2 hours.
Metabolism
Primarily metabolized in the liver via CYP3A4 pathway.
Side Effects
Contraindications
- Hypersensitivity to Enviral or any components.
- Severe hepatic impairment.
Drug Interactions
CYP3A4 inducers (e.g., Rifampicin)
May decrease Enviral plasma concentrations, reducing efficacy.
CYP3A4 inhibitors (e.g., Ketoconazole)
May increase Enviral plasma concentrations, increasing risk of side effects.
Storage
Store below 30°C in a dry place, away from direct sunlight.
Overdose
In case of overdose, seek immediate medical attention. Symptomatic and supportive treatment is recommended. Hemodialysis is unlikely to be effective.
Pregnancy & Lactation
Pregnancy Category C: Use only if potential benefit justifies potential risk to fetus. Consult a doctor during lactation.
Side Effects
Contraindications
- Hypersensitivity to Enviral or any components.
- Severe hepatic impairment.
Drug Interactions
CYP3A4 inducers (e.g., Rifampicin)
May decrease Enviral plasma concentrations, reducing efficacy.
CYP3A4 inhibitors (e.g., Ketoconazole)
May increase Enviral plasma concentrations, increasing risk of side effects.
Storage
Store below 30°C in a dry place, away from direct sunlight.
Overdose
In case of overdose, seek immediate medical attention. Symptomatic and supportive treatment is recommended. Hemodialysis is unlikely to be effective.
Pregnancy & Lactation
Pregnancy Category C: Use only if potential benefit justifies potential risk to fetus. Consult a doctor during lactation.
Frequently Asked Questions
Common questions about this medicine
Pack Sizes
Shelf Life
36 months
Availability
Currently unavailable (Fictional)
Approval Status
Investigational (Fictional Drug)
Patent Status
Patent Pending
Clinical Trials
Phase III trials are ongoing for various indications. Early results show promising efficacy and safety profile.
Lab Monitoring
- Liver function tests (LFTs)
- Renal function tests
Doctor Notes
- Monitor viral load and patient symptoms closely.
- Advise patients on adherence to full course of treatment.
Patient Guidelines
- Take with plenty of water.
- Do not share medication with others.
- Report any unusual side effects to your doctor.
Missed Dose Advice
Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose.
Driving Precautions
May cause dizziness; avoid driving or operating heavy machinery if affected.
Lifestyle Advice
- Maintain good hydration.
- Avoid alcohol during treatment.
Alternative Medicines in Bangladesh
Similar medicines available in the market
Global Brand Names
International brand names for this medicine. Click a brand to search for detailed information.